Supplementary Figures from A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non–Small Cell Lung Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figures. Supplemental Figure S1: Representative sections showing changes in expression between baseline biopsy and post-treatment surgical specimens. Supplemental Figure S2: Correlogram showing the correlation between changes in protein expression immunoscore, metabolic activity on PET and tumor size by CT scan.
Authors: Taofeek K. Owonikoko, Suresh S. Ramalingam, Daniel L. Miller, Seth D. Force, Gabriel L. Sica, Jennifer Mendel, Zhengjia Chen, Andre Rogatko, Mourad Tighiouart, R. Donald Harvey, Sungjin Kim, Nabil F. Saba, Allan Pickens, Madhusmita Behera, Robert W. Fu, Michael R. Rossi, William F. Auffermann, William E. Torres, Rabih Bechara, Xingming Deng, Shi-Yong Sun, Haian Fu, Anthony A. Gal, Fadlo R. Khuri
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361910367